Trinity Biotech (FRA:TRB) YoY Rev. per Sh. Growth : -49.97% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Trinity Biotech YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Trinity Biotech's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was -49.97%.

Trinity Biotech's Revenue per Share for the three months ended in Dec. 2023 was €0.97.

Trinity Biotech YoY Rev. per Sh. Growth Historical Data

The historical data trend for Trinity Biotech's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech YoY Rev. per Sh. Growth Chart

Trinity Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-3.06

25.52

-32.76

-43.70

-22.87

Trinity Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															126.43	-37.33	-22.02	-13.79	-49.97

Trinity Biotech YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Trinity Biotech's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(5.855	-	7.591)	/	\| 7.591 \|
=	-22.87 %

Trinity Biotech's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=	(Revenue per Share (Q: Dec. 2023 )	-	Revenue per Share (Q: Dec. 2022 ))	/	\| Revenue per Share (Q: Dec. 2022 )) \|
=	(0.973	-	1.945)	/	\| 1.945 \|
=	-49.97 %

Trinity Biotech YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Trinity Biotech (FRA:TRB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (FRA:TRB) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

STRR CNTG CHEK PMD MYNZ SLDX PRPO XWEL PCHM DMTK TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

TRIB:USA TRBA:Germany

Address

IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8

Website

https://www.trinitybiotech.com

Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.

Trinity Biotech (FRA:TRB) Headlines

No Headlines